Cargando…
‘Proteolytic switching’: opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
Although it is generally accepted that proteolytic degradation is an important mechanism used by malignant cells in the process of metastasis, comparatively little is known about the regulation of molecules responsible for proteolysis and how they become de-regulated during human tumour progression....
Autores principales: | MacDougall, J R, Bani, M R, Lin, Y, Muschel, R J, Kerbel, R S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1999
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362325/ https://www.ncbi.nlm.nih.gov/pubmed/10408860 http://dx.doi.org/10.1038/sj.bjc.6690385 |
Ejemplares similares
-
Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas
por: Forsyth, P A, et al.
Publicado: (1999) -
Endotoxemia shifts neutrophils with TIMP-free gelatinase B/MMP-9 from bone marrow to the periphery and induces systematic upregulation of TIMP-1
por: Vandooren, Jennifer, et al.
Publicado: (2017) -
MMP-9 and MMP-2 gelatinases and TIMP-1 and TIMP-2 inhibitors in breast cancer: correlations with prognostic factors
por: Jinga, D C, et al.
Publicado: (2006) -
Expression of neutrophil gelatinase-associated lipocalin (NGAL) in the gut in Crohn’s disease
por: Thorsvik, Silje, et al.
Publicado: (2018) -
Gelatinase B/MMP-9 in Tumour Pathogenesis and Progression
por: Farina, Antonietta Rosella, et al.
Publicado: (2014)